Analytical Data
-
Gene name
TUBa1C
- Application
-
Alternative Names
TUBA6
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BQE3
-
Expression Region
Met1~Asn300
-
Molecular Weight
42kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TUBa1C, a member of the tubulin protein family, plays a critical role in microtubule dynamics and organization, which are essential for various cellular functions including mitosis, intracellular transport, and cell shape maintenance. Research on TUBa1C has gained significance due to its implications in neurodevelopmental disorders and certain cancers, where aberrant microtubule function is often observed. Recent studies have highlighted the potential of TUBa1C as a therapeutic target, given its involvement in microtubule-based cellular processes. Moreover, the generation of recombinant TUBa1C protein has enabled scientists to explore its structural and biochemical properties in greater detail, facilitating the understanding of its role in cellular architecture. By studying TUBa1C in vitro, researchers aim to elucidate the mechanisms underlying its function and interactions with other proteins, paving the way for the development of targeted therapies that could mitigate disorders stemming from microtubule dysregulation. The recombinant expression of TUBa1C not only aids in the characterization of its functional domains but also provides insights into potential biomarkers for disease progression, reinforcing its relevance in biomedical research. As investigations continue, TUBa1C stands out as a promising candidate for further exploration in the context of therapeutic interventions and as a model to study the complex biology of tubulin-related processes in health and disease.
